drugset / Trial / NCT05521152

Norepinephrine for Prevention of Intraoperative Hypotension in Infants Undergoing Kasai Portoenterostomy

NCT05521152 ↗

Phase 3 Completed 31 enrolled Kasr El Aini Hospital
RandomizedParallel-groupTriple-blindPrevention

Summary

This study aims to assess the efficacy and safety of prophylactic intraoperative norepinephrine infusion versus the standard technique on decreasing the incidence of intraoperative hypotension in infants undergoing Kasai portoenterostomy operation.

Timeline

Start
2022-08-28
Primary completion
2024-07-08
Completion
2024-07-08

Outcome

Met primary endpoint

paper 12.5% (2 patients) in the norepinephrine group compared to 75% (12 patients) in the control group PMID 40250622 ↗

paper relative risk (95% confidence interval [CI]): 0.17 (0.04-0.63), p =  0.001 PMID 40250622 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Norepinephrine Other / unclassified 0.05 ug/kg —

Indications